International Edition
Latest News
Health

Most Children Labeled Allergic to Antibiotics Are Not Truly Allergic, Researchers Warn

“He can’t have penicillin or anything ending in -mycin,” a mother told Rebecca Payne as her 10-year-old son sat with severe tonsillitis in an urgent care center on a Saturday night, The Conversation reported. Around one in 20…

Most Children Labeled Allergic to Antibiotics Are Not Truly Allergic, Researchers Warn

“He can’t have penicillin or anything ending in -mycin,” a mother told Rebecca Payne as her 10-year-old son sat with severe tonsillitis in an urgent care center on a Saturday night, The Conversation reported.

Around one in 20 children in the United States carries a penicillin allergy label in their medical records, yet research suggests the vast majority are not truly allergic, according to a recent article in the British Journal of General Practice by Payne and colleagues. The label often follows the child into adulthood, steering clinicians toward broader-spectrum antibiotics that are less effective, more expensive, and drive antimicrobial resistance.

“Many childhood antibiotic allergy labels begin during viral infections,” Payne wrote. Viruses frequently cause rashes that coincide with antibiotic use, leading parents and clinicians to mistake the viral exanthem for a drug reaction. Vomiting, headaches, fever, and joint pain are also commonly misattributed to allergy.

Once entered, the allergy label is difficult to remove. Children with documented penicillin allergies face higher rates of infection with methicillin-resistant Staphylococcus aureus (MRSA) and Clostridioides difficile, longer hospital stays, and increased health-care costs, a BMJ study found.

Most Children Labeled Allergic to Antibiotics Are Not Truly Allergic, Researchers Warn
Photo: theconversation.com

UK guidance already provides a framework for removing inaccurate penicillin allergy labels in hospital settings. Research published in 2024 demonstrated that a structured approach in outpatient clinics and primary care safely removed allergy labels in 91% of children assessed, The Conversation reported.

The approach relies on a structured clinical history to place children into three categories:

  • Low risk: Original symptoms were never typical of allergy, the child has since tolerated the antibiotic, or the label was applied only because a family member has an allergy. The label can be removed without testing or referral.
  • Moderate risk: A mild rash occurred without systemic features such as breathing difficulty or hypotension. After assessment, a clinician may prescribe a single observed dose at home with follow-up in one week. If no reaction occurs, the label is removed.
  • High risk: History of anaphylaxis, severe cutaneous adverse reactions (such as mucosal involvement), or poorly controlled asthma. These children require referral to pediatric allergy or immunology services.

“Parents should never try giving their child an antibiotic again without medical advice,” Payne emphasized. The supervised challenge must be overseen by a general practitioner or practice pharmacist.

Retaining an unverified allergy label carries population-level risks. Broader-spectrum alternatives kill a wider range of bacteria than necessary, accelerating resistance and reducing the effectiveness of first-line agents for everyone, according to the British Journal of General Practice article.

“Keeping an uncertain allergy label can feel like the safest option for both parents and health care professionals,” Payne wrote. “But leaving an incorrect label in place carries risks too.”

If a child has an antibiotic allergy recorded, families should ask their general practitioner whether the diagnosis can be reviewed, ideally when the child is well. If the label is removed, the clinician should provide written confirmation and ensure the change is communicated to other relevant health-care providers.

Rebecca Payne, a researcher in the Division of Immunology, Immunity to Infection and Respiratory Medicine, co-authored a practical guide on antibiotic allergy de-labelling in children accepted by the British Journal of General Practice in September 2026. She previously described a common clinical scenario in which a child’s penicillin allergy label complicates treatment for severe tonsillitis, illustrating how viral rashes during antibiotic courses are often mistaken for drug reactions.

“That way, an assumption made years earlier is less likely to dictate a child’s future treatment,” Payne said.

About the author: Health Desk

Health Desk at Archynewsy.